Supplemental Material can be found at:
.html
macrophage cholesterol efflux through hydroxymethylglutaryl-
CoA reductase inhibition: a role for RhoA in ABCA1-mediated
cholesterol efflux. J. Biol. Chem. 280: 22212–22221.
studies have shown that the null mutation on the gene en-
coding lathosterol oxidase, which catalyses the formation
of ⌬5 to give cholesterol from lathosterol, led to a malfor-
mation syndrome known as lathosterolosis associated with
pre- or postnatal death (41).
20. Song, C., R. A. Hiipakka, and S. Liao. 2001. Auto-oxidized choles-
terol sulfates are antagonistic ligands of liver X receptors: implications
for the development and treatment of atherosclerosis. Steroids. 66:
473–479.
21. Berrodin, T. J., Q. Shen, E. M. Quinet, M. R. Yudt, L. P. Freedman,
and S. Nagpal. 2010. Identification of 5alpha, 6alpha-epoxyc-
holesterol as a novel modulator of liver X receptor activity. Mol.
Pharmacol. 78: 1046–1058.
The authors thank the members of the European Network on
Oxysterol Research (ENOR) for informative discussion.
22. Watabe, T., T. Sawahata, and J. Horie. 1979. Evidence for the for-
mation of a steroid S-glutathione conjugate from an epoxysteroid
precursor. Biochem. Biophys. Res. Commun. 87: 469–475.
23. Meyer, D. J., and B. Ketterer. 1982. 5 alpha,6 alpha-Epoxy-
cholestan-3 beta-ol (cholesterol alpha-oxide): a specific substrate
for rat liver glutathione transferase B. FEBS Lett. 150: 499–502.
24. Chan, J. T., and H. S. Black. 1974. Skin carcinogenesis: cholesterol-
5alpha,6alpha-epoxide hydrase activity in mouse skin irradiated
with ultraviolet light. Science. 186: 1216–1217.
25. Lo, W., and H. S. Black. 1973. Inhibition of carcinogen for-
mation in skin irradiated with ultraviolet light. Nature. 246:
489–491.
26. el-Bayoumy, K., B. Y. Ji, P. Upadhyaya, Y. H. Chae, C. Kurtzke, A.
Rivenson, B. S. Reddy, S. Amin, and S. S. Hecht. 1996. Lack of tu-
morigenicity of cholesterol epoxides and estrone-3,4-quinone in
the rat mammary gland. Cancer Res. 56: 1970–1973.
REFERENCES
1. Newman, J. W., C. Morisseau, and B. D. Hammock. 2005. Epoxide
hydrolases: their roles and interactions with lipid metabolism. Prog.
Lipid Res. 44: 1–51.
2. de Medina, P., M. R. Paillasse, G. Segala, M. Poirot, and S. Silvente-
Poirot. 2010. Identification and pharmacological characterization
of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and
AEBS ligands. Proc. Natl. Acad. Sci. USA. 107: 13520–13525.
3. Jordan, V. C. 2007. SERMs: meeting the promise of multifunctional
medicines. J. Natl. Cancer Inst. 99: 350–356.
4. Van Herendael, H., and P. Dorian. 2010. Amiodarone for the treat-
ment and prevention of ventricular fibrillation and ventricular
tachycardia. Vasc. Health Risk Manag. 6: 465–472.
5. Marques, L. O., M. S. Lima, and B. G. Soares. 2004. Trifluoperazine
for schizophrenia. Cochrane Database Syst. Rev. CD003545.
6. de Medina, P., S. Silvente-Poirot, and M. Poirot. 2009. Tamoxifen
and AEBS ligands induced apoptosis and autophagy in breast can-
cer cells through the stimulation of sterol accumulation. Autophagy.
5: 1066–1067.
7. de Medina, P., B. Payre, N. Boubekeur, J. Bertrand-Michel, F.
Terce, S. Silvente-Poirot, and M. Poirot. 2009. Ligands of the an-
tiestrogen-binding site induce active cell death and autophagy in
human breast cancer cells through the modulation of cholesterol
metabolism. Cell Death Differ. 16: 1372–1384.
27. Sheldrick, G. M. 1990. Phase annealing in SHELX-90: direct meth-
ods for larger structures. Acta Crystallogr. A. 46: 467–473.
28. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid
extraction and purification. Can. J. Biochem. Physiol. 37: 911–917.
29. Flack, H. D. 1983. On enantiomorph-polarity estimation. Acta
Crystallogr. A. 39: 876–881.
30. de Medina, P., S. Genovese, M. R. Paillasse, M. Mazaheri, S. Caze-
Subra, K. Bystricky, M. Curini, S. Silvente-Poirot, F. Epifano, and
M. Poirot. 2010. Auraptene is an inhibitor of cholesterol esterifi-
cation and a modulator of estrogen receptors. Mol. Pharmacol. 78:
827–836.
8. Payré, B., P. de Medina, N. Boubekeur, L. Mhamdi, J. Bertrand-
Michel, F. Terce, I. Fourquaux, D. Goudouneche, M. Record, M.
Poirot, et al. 2008. Microsomal antiestrogen-binding site ligands
induce growth control and differentiation of human breast can-
cer cells through the modulation of cholesterol metabolism. Mol.
Cancer Ther. 7: 3707–3718.
9. Martinez, G. R., A. P. Loureiro, S. A. Marques, S. Miyamoto, L. F.
Yamaguchi, J. Onuki, E. A. Almeida, C. C. Garcia, L. F. Barbosa, M.
H. Medeiros, et al. 2003. Oxidative and alkylating damage in DNA.
Mutat. Res. 544: 115–127.
10. Nielsen, L. P. C., and E. N. Jacobsen. 2006. Catalytic asymmet-
ric epoxide ring-opening chemistry. In Aziridines and Epoxide
in Organic Chemistry. A. K. Yudin, editor. Wiley-VCH Verlag,
Weinheim. 229–269.
11. Kolodiazhnyi, O. I. 2003. Multiple stereoselectivity and its applica-
tion in organic synthesis. Tetrahedron. 59: 5953–6018.
12. Parker, R. E., and N. S. Isaacs. 1959. Mechanisms of epoxide reac-
tions. Chem. Rev. 59: 737–799.
13. Marnett, L. J., J. N. Riggins, and J. D. West. 2003. Endogenous gen-
eration of reactive oxidants and electrophiles and their reactions
with DNA and protein. J. Clin. Invest. 111: 583–593.
14. Koskinen, M., and K. Plná. 2000. Specific DNA adducts induced
by some mono-substitued epoxides in vitro and in vivo. Chem. Biol.
Interact. 129: 209–229.
15. Schroepfer, G. J., Jr. 2000. Oxysterols: modulators of cholesterol
metabolism and other processes. Physiol. Rev. 80: 361–554.
16. Watabe, T., and T. Sawahata. 1979. Biotransformation of cho-
lesterol to cholestane-3beta,5alpha,6beta-triol via cholesterol
alpha-epoxide (5alpha,6alpha-epoxycholestan-3beta-ol) in bovine
adrenal cortex. J. Biol. Chem. 254: 3854–3860.
31. de Medina, P., N. Boubekeur, P. Balaguer, G. Favre, S. Silvente-
Poirot, and M. Poirot. 2006. The prototypical inhibitor of
cholesterol esterification, Sah 58–035 [3-[decyldimethylsilyl]-n-[2-
(4-methylphenyl)-1-phenylethyl]propanamide], is an agonist of es-
trogen receptors. J. Pharmacol. Exp. Ther. 319: 139–149.
32. Bond, J. A. 1989. Review of the toxicology of styrene. Crit. Rev.
Toxicol. 19: 227–249.
33. Murphy, R. C., and K. M. Johnson. 2008. Cholesterol, reactive ox-
ygen species, and the formation of biologically active mediators.
J. Biol. Chem. 283: 15521–15525.
34. Massey, J. B., and H. J. Pownall. 2006. Structures of biologically ac-
tive oxysterols determine their differential effects on phospholipid
membranes. Biochemistry. 45: 10747–10758.
35. Benedetti, F., F. Berti, S. Fabrissin, and T. Gianferrara. 1994.
Intramolecular ring opening of epoxides by bis-activated carban-
ions. The influence of ring size on reactivity and selectivity. J. Org.
Chem. 59: 1518–1524.
36. Furst, A., and P. A. Plattner. 1949. Uber steroide und sexual hor-
mone. Helv. Chim. Acta. 32: 275–283.
37. Jágr, M., J. Mraz, I. Linhart, V. Stransky, and M. Pospisil. 2007.
Synthesis and characterization of styrene oxide adducts with
cysteine, histidine, and lysine in human globin. Chem. Res. Toxicol.
20: 1442–1452.
38. Smith, L. L. 1991. Another cholesterol hypothesis: cholesterol as
antioxidant. Free Radic. Biol. Med. 11: 47–61.
39. de Medina, P., M. R. Paillasse, B. Payre, S. Silvente-Poirot, and M.
Poirot. 2009. Synthesis of new alkylaminooxysterols with potent
cell differentiating activities: identification of leads for the treat-
ment of cancer and neurodegenerative diseases. J. Med. Chem. 52:
7765–7777.
40. Xu, F., S. D. Rychnovsky, J. D. Belani, H. H. Hobbs, J. C. Cohen,
and R. B. Rawson. 2005. Dual roles for cholesterol in mammalian
cells. Proc. Natl. Acad. Sci. USA. 102: 14551–14556.
41. Krakowiak, P. A., C. A. Wassif, L. Kratz, D. Cozma, M. Kovarova,
G. Harris, A. Grinberg, Y. Yang, A. G. Hunter, M. Tsokos, et al.
2003. Lathosterolosis: an inborn error of human and murine cho-
lesterol synthesis due to lathosterol 5-desaturase deficiency. Hum.
Mol. Genet. 12: 1631–1641.
17. Zhang, Y., C. Yu, J. Liu, T. A. Spencer, C. C. Chang, and T. Y.
Chang. 2003. Cholesterol is superior to 7-ketocholesterol or 7
alpha-hydroxycholesterolasanallostericactivatorforacyl-coenzyme
A:cholesterol acyltransferase 1. J. Biol. Chem. 278: 11642–11647.
18. Fuda, H., N. B. Javitt, K. Mitamura, S. Ikegawa, and C. A. Strott.
2007. Oxysterols are substrates for cholesterol sulfotransferase.
J. Lipid Res. 48: 1343–1352.
19. Argmann, C. A., J. Y. Edwards, C. G. Sawyez, C. H. O’Neil, R. A.
Hegele, J. G. Pickering, and M. W. Huff. 2005. Regulation of
Cholesterol-5,6-epoxides are not spontaneous alkylating epoxides
725